Search results
Psoriatic Arthritis Drugs Comparably Improve Joint Outcomes
Medscape· 3 days agoReal-world study data suggest there is little difference among five drug classes commonly used to...
J&J (JNJ) Seeks Expanded Use of Tremfya for Crohn's Disease
Zacks via Yahoo Finance· 9 hours agoJ&J (JNJ) seeks label expansion for Tremfya for treating moderately to severely active Crohn's...
Izokibep Marches on for Psoriatic Arthritis
MedPage Today· 6 days agoAfter 16 weeks of treatment in the randomized, placebo-controlled study, 40% and 43% of patients receiving 160 mg of izokibep weekly or biweekly,...
Psoriasis study shows high level of arthritis symptoms in patients
Medical Xpress· 3 days agoThe 25% figure confirms existing knowledge that up to a third will go on to develop psoriatic ...
Izokibep Enthesitis Benefit Lacking in Phase 2b/3 PsA Trial
Medscape· 3 days agoThe primary efficacy endpoint was met, but the novel small molecule therapeutic did not reduce...
Study led by UChicago Medicine physician finds new | Newswise
Newswise· 5 days agoA medication used for psoriasis and psoriatic arthritis is proving to be an effective treatment for moderate to severe ulcerative colitis in the findings ...
Walking Helps Guard Against Recurrent Low Back Pain
Medscape· 2 days agoRegular walking can help prevent recurrent episodes of low back pain, a new study suggests. Among adults who recently recovered from an episode of low...
Phase 3 Trial Supports Ixekizumab in Juvenile PsA, ERA
Medscape· 2 days agoIxekizumab (Taltz), an interleukin-17A inhibitor that's already approved for the treatment of ...
Cardinal Capital Management Inc. Sells 3,561 Shares of AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 6 hours agoCardinal Capital Management Inc. cut its position in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 1.8% during the 1st quarter, according to the company in its most recent Form 13F filing ...
AbbVie Inc. (NYSE:ABBV) Shares Sold by Stableford Capital II LLC
ETF DAILY NEWS· 6 hours agoStableford Capital II LLC decreased its stake in AbbVie Inc. (NYSE:ABBV – Free Report) by 6.2% in the 1st quarter, Holdings Channel reports. The firm owned 5,038 shares of the company’s stock ...